IMAXIMAX
About: Imax Corp is a premier global technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers a unique end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. Top filmmakers, movie studios, artists, and creators utilize the cutting-edge visual and sound technology of IMAX to connect with audiences in innovative ways. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
Employees: 697
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
79% more call options, than puts
Call options by funds: $42.1M | Put options by funds: $23.5M
38% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 24
28% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 46
24% more capital invested
Capital invested by funds: $752M [Q2] → $929M (+$177M) [Q3]
6% more funds holding
Funds holding: 160 [Q2] → 169 (+9) [Q3]
0.55% more ownership
Funds ownership: 85.19% [Q2] → 85.74% (+0.55%) [Q3]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q2] → 1 (+0) [Q3]
Research analyst outlook
5 Wall Street Analysts provided 1 year price targets over the past 3 months
5 analyst ratings
Benchmark Mike Hickey 79% 1-year accuracy 59 / 75 met price target | 22%upside $30 | Buy Maintained | 13 Dec 2024 |
Barrington Research James Goss 55% 1-year accuracy 53 / 96 met price target | 14%upside $28 | Outperform Maintained | 1 Nov 2024 |
Roth MKM Eric Handler 93% 1-year accuracy 25 / 27 met price target | 14%upside $28 | Buy Maintained | 31 Oct 2024 |
Rosenblatt Steve Frankel 72% 1-year accuracy 21 / 29 met price target | 14%upside $28 | Buy Maintained | 31 Oct 2024 |
JP Morgan David Karnovsky 68% 1-year accuracy 17 / 25 met price target | 14%downside $21 | Neutral Maintained | 14 Oct 2024 |
Financial journalist opinion
Based on 16 articles about IMAX published over the past 30 days